Breaking

Drill Rig Mobilised at Lo Herma ISR Uranium Project
JZR Gold Announces First Concentrate From Vila Nova Gold Project
FALCO ANNOUNCES INCREASE TO PREVIOUSLY ANNOUNCED BOUGHT DEAL FINANCING
Josef Schachter: Oil/Gas Stock Buy Window — 3 Signals to Watch
Blackrock Announces Arrangements to Address Mailing of Meeting Materials Resulting from the Canada Post Strike
Silver Hammer Announces Receipt of Updated and Revised Drill Permit for Upcoming Silverton Project Exploration Program in Nevada
Empire Metals Limited – MRE Confirms World Dominant Titanium Discovery
IsoEnergy Expands Into Australia with Toro Energy Takeover

Facebook
Twitter
Google Plus
Instagram
Pinterest
Vimeo

Investing
Stock
Latest News
Editor’s Pick
Economy
Search for:

Investing

RAD Doses 1st Patient in Therapeutic Trial of 177Lu-RAD202

By June 4, 2025

Share on Facebook Share on Twitter Pinterest LinkedIn Tumblr Email

Share

Share on Facebook Share on Twitter Pinterest Email

Radiopharm Theranostics (RAD:AU) has announced RAD Doses 1st Patient in Therapeutic Trial of 177Lu-RAD202

Download the PDF here.

This post appeared first on investingnews.com

0

Related Posts

Drill Rig Mobilised at Lo Herma ISR Uranium Project

October 15, 2025

JZR Gold Announces First Concentrate From Vila Nova Gold Project

October 15, 2025

FALCO ANNOUNCES INCREASE TO PREVIOUSLY ANNOUNCED BOUGHT DEAL FINANCING

October 15, 2025

Enter Your Information Below To Receive Latest News, And Articles.
Your name

Your email
Your information is secure and your privacy is protected. By opting in you agree to receive emails from us. Remember that you can opt-out any time, we hate spam too!

Latest Posts
Categories
- Economy (1,012)
- Editor's Pick (588)
- Investing (4,569)
- Latest News (3,536)
- Stock (1,161)
About Rightinvestingway

Disclaimer: Rightinvestingway.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

Copyright © 2025 Rightinvestingway.com

Top

Type above and press Enter to search. Press Esc to cancel.